eagle-i Oregon Health and Science UniversityOregon Health and Science University
See it in Search

Layton Aging & Alzheimer's Disease Center

Summary:

Serving Oregon and the Northwest since 1989, our vision is to add life to years, not simply years to life.

Affiliations:

People:

    Resources:

    Biological Specimens

    • Human blood plasma ( Biological Specimen )

      Human blood plasma samples from participants in a variety of brain-related studies, including OADC clinic recruited subjects, Oregon Brain Aging Study, Community Brain Donor Program, Preventing Cognitive Decline with Alternative Therapies, African American Dementia and aging Project, Klamath Exceptional Aging Project, Late Onset Familial Alzheimer Disease Kindreds.

    • Human brain and central nervous system tissue ( Biological Specimen )

      Tissue samples from brains of individuals who have been followed longitudinally in the Oregon Alzheimer’s Disease Center Clinical Core.

    • Human cerebrospinal fluid ( Biological Specimen )

      Human CSF samples from participants in a variety of brain-related studies, including OADC clinic recruited subjects, Oregon Brain Aging Study, Community Brain Donor Program, Preventing Cognitive Decline with Alternative Therapies, African American Dementia and aging Project, Klamath Exceptional Aging Project, Late Onset Familial Alzheimer Disease Kindreds.

    • Human genomic DNA samples ( Biological Specimen )

      Human genomic DNA samples from participants in a variety of brain-related studies, including OADC clinic recruited subjects, Oregon Brain Aging Study, Community Brain Donor Program, Preventing Cognitive Decline with Alternative Therapies, African American Dementia and aging Project, Klamath Exceptional Aging Project, Late Onset Familial Alzheimer Disease Kindreds.

    Services

    • Comprehensive collection of activity data on study participants ( Support service )

      Includes: Data and measures derived from in-home assessment technologies (e.g., walking speed, total activity, patterns of activity over time), data and measures derived from computer use (e.g., total computer use, average time in application, inter-keystroke interval; note that which websites are visited or what whole words are typed are NOT collected due to privacy considerations), data from weekly on-line health questionnaires (e.g., falls, depression, medication changes); note that this information is collected monthly by telephone for subjects who do not use a computer.
      Data and measures derived from bed mats or load cells on the bed (e.g., total time in bed, sleep restlessness), data and measures derived from use of MedTracker device (e.g., percent compliance, time of pill taking), data and measures derived from additional in-home technologies (e.g., GPS cell phones)

    • Human SNP genomic analysis results ( Access service )

      "Genotypes Data:
      APOE
      Genome-Wide and candidate region SNP marker data on various platforms*
      AD Candidate gene markers* (e.g. CYP46, MTHFR, HLA, Tau)
      * These are available only on a limited subset of subjects."


    Web Links:

    Last updated: 2013-10-31T13:01:13.854-05:00

    Copyright © 2016 by the President and Fellows of Harvard College
    The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016